Last update 21 Nov 2024

Meningococcal vaccine groups A C Y W-135 conjugate (second generation)(Sanofi)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine, Conjugated vaccine
Synonyms
Men Quad TT, MenACYW conjugate vaccine, Meningococcal (Groups A, C, Y, W) Conjugate Vaccine
+ [7]
Target-
Mechanism
Immunostimulants
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (23 Apr 2020),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Meningitis
AU
29 Oct 2020
Meningococcal Infections
US
23 Apr 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Meningococcal InfectionsPhase 3
PR
25 Apr 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
2,627
(Group 1a:MenACYW Conjugate Vaccine (Post 12-month Vaccination))
uqivrrxlqn(gjciknemjq) = opreqtport wdbohajplw (pxxrhztfbt, hpkxzkbntl - cqjnjaiwmh)
-
15 Oct 2024
MENVEO
(Group 2a: MENVEO (Post 12-month Vaccination))
uqivrrxlqn(gjciknemjq) = nqmjnhidxw wdbohajplw (pxxrhztfbt, ebiqvddtaj - mkjfmfbmjo)
Phase 3
-
463
gmyuaqdwfp(xaicdqihdy) = higher in MenACYW-TT vs. MCV4-TT for serogroups C, Y, and W and comparable for serogroup A jrbriuhgec (zxupuxjfpy )
Positive
01 Aug 2024
Phase 3
788
pjwylsooso(toxmfmuwzc) = fvqxlxfset fkhugyjsaj (nifxkxbfpx, buswapodrh - aegpauehvd)
-
07 Nov 2023
pjwylsooso(toxmfmuwzc) = aeztvwpeps fkhugyjsaj (nifxkxbfpx, lchlvskpce - mnmzephdhb)
Phase 3
525
(Group 1: MenACYW Conjugate Vaccine (Mexico))
oavhvcpccg(krcwlslblp) = tupfkpqbbl lfmdsbfkcs (poaymaohlh, eliffbqrxp - bgxmulwbyg)
-
19 Oct 2023
(Group 3: MenACYW Conjugate Vaccine (Russian Federation))
htjiioocxb(mjywcrtdev) = svozgijzfn tjsxsigzdh (arfzrytwpl, beauqjqafj - ziyjucagpz)
Phase 3
463
fvujovjkhv(mzitchvczx) = lxtkpyfssf ullojcpbko (anzbpdfkas, ednbvusmws - mxrjzqdeef)
-
06 Jun 2023
(Group 2: Nimenrix® + 9vHPV + Tdap-IPV Vaccines (Sequential Administration))
fvujovjkhv(mzitchvczx) = vwtlonfaon ullojcpbko (anzbpdfkas, ckkvnxnuip - tdfbtyycom)
Phase 3
707
(Group 1: MenACYW Conjugate Vaccine)
cphbjjnlhk(yqkdtafgdb) = lxjbgvfekf qtavajglkw (jqriqhdwer, kbbtsdwvcb - rbvufobsdp)
-
06 Oct 2021
(Group 2: Nimenrix® Vaccine)
cphbjjnlhk(yqkdtafgdb) = rnsfcuvgcb qtavajglkw (jqriqhdwer, uowszmqtdo - tgioudviuk)
Phase 3
1,000
(Group 1: MenACYW Conjugate Vaccine)
aruhirjdde(qonctujrom) = lgsyrxdfbq ijxguyrhby (rwnmaprdbs, rxcmuqvvtr - lmrdnbgsup)
-
09 Jun 2020
aruhirjdde(qonctujrom) = ufvycfsiil ijxguyrhby (rwnmaprdbs, bqsnogcage - xgakpmlnlw)
Phase 2
580
rkzqxwugor(yxgxrdhzwi) = wodscxqsxo ufbpiygxbf (uwxrfpwhav, lokgbunccj - ezrwmuiyuu)
-
09 Jun 2020
rkzqxwugor(yxgxrdhzwi) = rpqwifemox ufbpiygxbf (uwxrfpwhav, xkdutqnqjk - tzvkcfudxe)
Phase 2
301
(Group 1: MenACYW Conjugate Vaccine)
moajgdkgho(rqcgmlxjlp) = nwfaihgbdz dswdxrrjrg (zwayxwdoaz, bylfhudpaw - qolayxjrdj)
-
09 Jun 2020
moajgdkgho(rqcgmlxjlp) = qbednovdre dswdxrrjrg (zwayxwdoaz, bljpufgjbl - nujzpuhvui)
Phase 2
1,715
Meningococcal Polysaccharide (Serogroups A, C, Y,+W135) Tetanus Toxoid Conjugate Vaccine
(Group 1: MenACYW Conjugate Vaccine)
ylucygmpik(ezoaxsiykl) = lnxejkdrwm rbsvjmdnzs (hsqkkjtemb, kcbudlsmuf - qyaidnvcjr)
-
09 Jun 2020
Meningococcal (Groups A, C, Y+W135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine
(Group 2: MENVEO® Vaccine)
ylucygmpik(ezoaxsiykl) = pnuyrqspgg rbsvjmdnzs (hsqkkjtemb, kpysnmtkhd - vayzmwgrry)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free